29,244 results on '"ADULT respiratory distress syndrome"'
Search Results
152. Progressive changes in pulmonary gas exchange during invasive respiratory support for COVID‐19 associated acute respiratory failure: A retrospective study of the association with 90‐day mortality.
- Author
-
Konsberg, Ylva, Åneman, Anders, Olsen, Fredrik, Hessulf, Fredrik, Nellgård, Bengt, Hård af Segerstad, Mathias, and Dalla, Keti
- Subjects
- *
PULMONARY gas exchange , *ADULT respiratory distress syndrome , *COVID-19 , *MORTALITY , *INTENSIVE care units - Abstract
Background: Ratio of arterial pressure of oxygen and fraction of inspired oxygen (P/F ratio) together with the fractional dead space (Vd/Vt) provides a global assessment of pulmonary gas exchange. The aim of this study was to assess the potential value of these variables to prognosticate 90‐day survival in patients with COVID‐19 associated ARDS admitted to the Intensive Care Unit (ICU) for invasive ventilatory support. Methods: In this single‐center observational, retrospective study, P/F ratios and Vd/Vt were assessed up to 4 weeks after ICU‐admission. Measurements from the first 2 weeks were used to evaluate the predictive value of P/F ratio and Vd/Vt for 90‐day mortality and reported by the adjusted hazard ratio (HR) and 95% confidence intervals [95%CI] by Cox proportional hazard regression. Results: Almost 20,000 blood gases in 130 patients were analyzed. The overall 90‐day mortality was 30% and using the data from the first ICU week, the HR was 0.85 [0.77–0.94] for every 10 mmHg increase in P/F ratio and 1.61 [1.20–2.16] for every 0.1 increase in Vd/Vt. In the second week, the HR for 90‐day mortality was 0.82 [0.75–0.89] for every 10 mmHg increase in P/F ratio and 1.97 [1.42–2.73] for every 0.1 increase in Vd/Vt. Conclusion: The progressive changes in P/F ratio and Vd/Vt in the first 2 weeks of invasive ventilatory support for COVID‐19 ARDS were significant predictors for 90‐day mortality. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
153. Drug-induced lung disease: a narrative review.
- Author
-
Posses Bridi, Guilherme das, Ururahy Nunes Fonseca, Eduardo Kaiser, Adib Kairalla, Ronaldo, Franco Amaral, Alexandre, and Guedes Baldi, Bruno
- Subjects
ORGANIZING pneumonia ,ADULT respiratory distress syndrome ,PULMONARY edema ,LUNG diseases ,ANTIRHEUMATIC agents - Abstract
Drug-induced lung disease (DILD) encompasses a broad, highly heterogeneous group of conditions that may occur as a result of exposure to numerous agents, such as antineoplastic drugs, conventional or biological disease-modifying antirheumatic drugs, antiarrhythmics, and antibiotics. Between 3% and 5% of prevalent cases of interstitial lung diseases are reported as DILDs. The pathogenesis of lung injury in DILD is variable, multifactorial, and often unknown. Acute presentation is the most common, can occur from days to months after the start of treatment, and ranges from asymptomatic to acute respiratory failure. The CT patterns are varied and include groundglass opacities, organizing pneumonia, and diffuse alveolar damage. Notably, there are no clinical manifestations or CT patterns specific to DILD, which makes the diagnosis quite challenging and necessitates a high index of suspicion, as well as the exclusion of alternative causes such as infection, cardiac-related pulmonary edema, exacerbation of a preexisting ILD, and neoplastic lung involvement. Discontinuation of the offending medication constitutes the cornerstone of treatment, and corticosteroid treatment is usually necessary after the onset of clinical manifestations. The prognosis varies widely, with high mortality rates in severe cases. A history of medications related to pulmonary toxicity in patients with new-onset respiratory symptoms should prompt consideration of DILD as a potential underlying cause. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
154. Optimal Prone Position Duration in Patients With ARDS Due to COVID-19: The Omelette Pilot Trial.
- Author
-
Sáez de la Fuente, Ignacio, Marcos Morales, Adrián, Muñoz Calahorro, Reyes, Álvaro Valiente, Elena, Sánchez-Bayton Griffith, María, Chacón Alves, Silvia, Molina Collado, Zaira, González de Aledo, Amanda Lesmes, Martín Badía, Isaías, González Fernández, María, Orejón García, Lidia, Arribas López, Primitivo, Temprano Vázquez, Susana, and Sánchez Izquierdo Riera, José Ángel
- Subjects
ADULT respiratory distress syndrome treatment ,SKELETAL muscle injuries ,CONTINUING education units ,BLOOD gases analysis ,PEARSON correlation (Statistics) ,ADULT respiratory distress syndrome ,DATA analysis ,LYING down position ,PILOT projects ,STATISTICAL sampling ,MULTIPLE regression analysis ,FISHER exact test ,TREATMENT duration ,TREATMENT effectiveness ,RANDOMIZED controlled trials ,HOSPITALS ,SEVERITY of illness index ,HOSPITAL mortality ,MANN Whitney U Test ,CHI-squared test ,MULTIVARIATE analysis ,DESCRIPTIVE statistics ,KAPLAN-Meier estimator ,ARTIFICIAL respiration ,INTENSIVE care units ,RESPIRATORY organ physiology ,STATISTICS ,FRIEDMAN test (Statistics) ,CONFIDENCE intervals ,EXTUBATION ,LENGTH of stay in hospitals ,AIRWAY (Anatomy) ,DATA analysis software ,COVID-19 ,NEUROMUSCULAR blocking agents ,ANESTHESIA ,REGRESSION analysis ,EVALUATION - Abstract
Background: Prone position (PP) has been widely used in the COVID-19 pandemic for ARDS management. However, the optimal length of a PP session is still controversial. This study aimed to evaluate the effects of prolonged versus standard PP duration in subjects with ARDS due to COVID-19. Methods: This was a single-center, randomized controlled, parallel, and open pilot trial including adult subjects diagnosed with severe ARDS due to COVID-19 receiving invasive mechanical ventilation that met criteria for PP between March-September 2021. Subjects were randomized to the intervention group of prolonged PP (48 h) versus the standard of care PP (-16 h). The primary outcome variable for the trial was ventilator-free days (VFDs) to day 28. Results: We enrolled 60 subjects. VFDs were not significantly different in the standard PP group (18 [interquartile range [IQR] 0-23] VFDs vs 7.5 [IQR 0-19.0] VFDs; difference, -10.5 (95% CI -3.5 to 19.0, P = .08). Prolonged PP was associated with longer time to successful extubation in survivors (13.00 [IQR 8.75-26.00] d vs 8.00 [IQR 5.00-10.25] d; difference, 5 [95% CI 0-15], P = .001). Prolonged PP was also significantly associated with longer ICU stay (18.5 [IQR 11.8-25.3] d vs 11.50 [IQR 7.75-25.00] d, P = .050) and extended administration of neuromuscular blockers (12.50 [IQR 5.75-20.00] d vs 5.0 [IQR 2.0-14.5] d, P = .005). Prolonged PP was associated with significant muscular impairment according to lower Medical Research Council values (59.6 [IQR 59.1-60.0] vs 56.5 [IQR 54.1-58.9], P = .02). Conclusions: Among subjects with severe ARDS due to COVID-19, there was no difference in 28-d VFDs between prolonged and standard PP strategy. However, prolonged PP was associated with a longer ICU stay, increased use of neuromuscular blockers, and greater muscular impairment. This suggests that prolonged PP is not superior to the current recommended standard of care. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
155. 循环组蛋白诱导内皮功能障碍致脓毒症急性呼吸 窘迫综合征的机制研究.
- Author
-
杨汀航, 李育霈, and 苏白海
- Subjects
VASCULAR endothelial cells ,ADULT respiratory distress syndrome ,CELL junctions ,ADHERENS junctions ,CADHERINS ,MORTALITY risk factors ,ENDOTHELIUM diseases - Abstract
Copyright of Journal of Sichuan University (Medical Science Edition) is the property of Editorial Board of Journal of Sichuan University (Medical Sciences) and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2024
156. Transcription factor NF-E2-related factor 2 plays a critical role in acute lung injury/acute respiratory distress syndrome (ALI/ARDS) by regulating ferroptosis.
- Author
-
Deng, JiaLi, Li, Na, Hao, Liyuan, Li, Shenghao, Aiyu, Nie, Zhang, Junli, and Hu, XiaoYu
- Subjects
TRANSCRIPTION factors ,NUCLEAR factor E2 related factor ,ADULT respiratory distress syndrome ,REACTIVE oxygen species ,GENETIC transcription regulation - Abstract
NRF2 is an important transcription factor that regulates redox homeostasis in vivo and exerts its anti-oxidative stress and anti-inflammatory response by binding to the ARE to activate and regulate the transcription of downstream protective protein genes, reducing the release of reactive oxygen species. Ferroptosis is a novel iron-dependent, lipid peroxidation-driven cell death mode, and recent studies have shown that ferroptosis is closely associated with acute lung injury/acute respiratory distress syndrome (ALI/ARDS). NRF2 is able to regulate ferroptosis through the regulation of the transcription of its target genes to ameliorate ALI/ARDS. Therefore, This article focuses on how NRF2 plays a role in ALI/ARDS by regulating ferroptosis. We further reviewed the literature and deeply analyzed the signaling pathways related to ferroptosis which were regulated by NRF2. Additionally, we sorted out the chemical molecules targeting NRF2 that are effective for ALI/ARDS. This review provides a relevant theoretical basis for further research on this theory and the prevention and treatment of ALI/ARDS. The intended audience is clinicians and researchers in the field of respiratory disease. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
157. Electrocardiographic parameters and mortality in patients with SARS-CoV-2 infection: A single center study.
- Author
-
Esmaeilzad, Samaneh Karbalaie, Hedayati, Mohammad Taghi, Ziaie, Naghmeh, Shirafkan, Hoda, Jalali, Farzad, Jafaripoor, Iraj, Amin, Kamyar, Pourkia, Rogheyeh, Jabbary, Zahra, Abroutan, Saeid, and Saravi, Mehrdad
- Subjects
ARRHYTHMIA ,BRUGADA syndrome ,COVID-19 ,BUNDLE-branch block ,SARS-CoV-2 ,ADULT respiratory distress syndrome ,VENTRICULAR arrhythmia - Abstract
Background: Coronavirus disease 2019 (COVID-19) is a pandemic outbreak of RNA coronaviruses (SARS-CoV-2), associated with acute respiratory distress syndrome, multiple organ failure, and death. The surface electrocardiogram is the first line assessment of cardiac electrical system. We aimed to interpret classically the electrocardiographic parameters at admission and during hospital course and association of them with prognosis in patients admitted with diagnosis of infection with SARSCoV- 2. Methods: Surface electrocardiograms (ECG) were obtained from 180 patients with SARS-CoV-2 infection at a large tertiary referral university hospital at north of Iran in Babol. The electrocardiographic waves, intervals and segments in addition to supraventricular and ventricular arrhythmias were depicted. Our cohort included two groups: discharged alive and dead during the hospital course. We compared the ECG characteristics of patients who died vs. survived ones. Results: Some ECG parameters of 180 hospitalized patients were significantly associated with mortality, like heart rate (p< 0.001), bundle branch block (P= 0.035), fragmented QRS (P= 0.015), ST elevation (P= 0.004), T p-e duration (P= 0.006), premature atrial and ventricular complexes (P= 0.030, P= 0.004) and atrial fibrillation (P= 0.003). Conclusion: The SARS-CoV-2 infection had several impacts on cardiac electrical system which may monitored with a simple and easily accessible tool like ECG. This tool also helpful in the risk stratification of patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
158. A narrative review of chemokine receptors CXCR1 and CXCR2 and their role in acute respiratory distress syndrome.
- Author
-
Toya, Sophie, Struyf, Sofie, Huerta, Luis, Morris, Peter, Gavioli, Elizabeth, Maria Minnella, Enrico, Candida Cesta, Maria, Allegretti, Marcello, and Proost, Paul
- Subjects
ADULT respiratory distress syndrome ,CHEMOKINE receptors ,CXCR4 receptors ,G protein coupled receptors ,ACTIVATED protein C resistance ,BLOOD platelet aggregation - Abstract
Acute respiratory distress syndrome (ARDS) is a severe form of acute respiratory failure characterised by extensive inflammatory injury to the alveolocapillary barrier leading to alveolar oedema, impaired gas exchange and, ultimately, hypoxaemia necessitating the use of supplemental oxygen combined with some degree of positive airway pressure. Although much heterogeneity exists regarding the aetiology, localisation and endotypic characterisation of ARDS, what remains largely undisputed is the role of the innate immune system, and in particular of neutrophils, in precipitating and propagating lung injury. Activated neutrophils, recruited to the lung through chemokine gradients, promote injury by releasing oxidants, proteases and neutrophil extracellular traps, which ultimately cause platelet aggregation, microvascular thrombosis and cellular death. Among various neutrophilic chemoattractants, interleukin-8/ C-X-C motif ligand 8 and related chemokines, collectively called ELR+ chemokines, acting on neutrophils through the G protein-coupled receptors CXCR1 and CXCR2, are pivotal in orchestrating the neutrophil activation status and chemotaxis in the inflamed lung. This allows efficient elimination of infectious agents while at the same time minimising collateral damage to host tissue. Therefore, understanding how CXCR1 and CXCR2 receptors are regulated is important if we hope to effectively target them for therapeutic use in ARDS. In the following narrative review, we provide an overview of the role of ELR+ chemokines in acute lung injury (ALI) and ARDS, we summarise the relevant regulatory pathways of their cognisant receptors CXCR1/2 and highlight current preclinical and clinical evidence on the therapeutic role of CXCR1 and CXCR2 inhibition in animal models of ALI, as well as in ARDS patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
159. IL-10 Counteracts IFN-γ to Alleviate Acute Lung Injury in a Viral-Bacterial Superinfection Model.
- Author
-
McKelvey, Michael, Uddin, Md Bashir, Palani, Sunil, Shao, Shengjun, and Sun, Keer
- Subjects
SUPERINFECTION ,VIRUS diseases ,INTERLEUKIN-10 ,ADULT respiratory distress syndrome ,LUNG injuries ,METHICILLIN-resistant staphylococcus aureus ,MACROPHAGES - Abstract
Immune activation is essential for lung control of viral and bacterial infection, but an overwhelming inflammatory response often leads to the onset of acute respiratory distress syndrome. IL-10 plays a crucial role in regulating the balance between antimicrobial immunity and immunopathology. In the present study, we investigated the role of IL-10 in acute lung injury induced by influenza A virus and methicillin-resistant Staphylococcus aureus coinfection. This unique coinfection model resembles patients with acute pneumonia undergoing appropriate antibiotic therapies. Using global IL-10 and IL-10 receptor gene-deficient mice, as well as in vivo neutralizing antibodies, we show that IL-10 deficiency promotes IFN-γ–dominant cytokine responses and triggers acute animal death. Interestingly, this extreme susceptibility is fully preventable by IFN-γ neutralization during coinfection. Further studies using mice with Il10ra deletion in selective myeloid subsets reveal that IL-10 primarily acts on mononuclear phagocytes to prevent IFN-γ/TNF-α hyperproduction and acute mortality. Importantly, this antiinflammatory IL-10 signaling is independent of its inhibitory effect on antiviral and antibacterial defense. Collectively, our results demonstrate a key mechanism of IL-10 in preventing hypercytokinemia and acute respiratory distress syndrome pathogenesis by counteracting the IFN-γ response. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
160. Actualités en médecine d’urgence.
- Author
-
Bouzid, D., Jonchier, M., Rousseau, G., Guenezan, J., Pechanski, N., and Villoing, B.
- Subjects
MYOCARDIAL infarction risk factors ,MORTALITY risk factors ,RISK assessment ,TROPONIN ,ADRENOCORTICAL hormones ,ADULT respiratory distress syndrome ,KETAMINE ,MORPHINE ,HEALTH ,EMERGENCY medicine ,INFORMATION resources ,HYDROCORTISONE ,HOSPITAL emergency services ,RESPIRATORY syncytial virus infections ,INFLUENZA ,PRESS ,COMMUNITY-acquired pneumonia ,SEPTIC shock ,DICLOFENAC ,DISEASES ,SEPSIS ,PAIN ,MEDICAL appointments ,IBUPROFEN ,LUMBAR pain ,CELL receptors ,DISEASE complications ,OLD age - Published
- 2024
- Full Text
- View/download PDF
161. Extracorporeal Life Support Use in Mixed Distributive–Obstructive Shock Following an Electrical Injury: A Case Report.
- Author
-
Blake, Eva, Maqsood, Hannan A, Dougherty, Jacob M, Vercruysse, Gary, Wang, Stewart C, Hemmila, Mark R, and Sangji, Naveen F
- Subjects
ELECTRICAL burns ,EXTRACORPOREAL membrane oxygenation ,ADULT respiratory distress syndrome ,LEG amputation ,DISABILITIES ,ELECTRICAL injuries - Abstract
Electrical burn injuries can be catastrophic, threatening severe disability or mortality. We present a patient who suffered from electrical shock, requiring bilateral above-knee amputations, right trans-radial amputation, renal replacement therapy, and veno-arterial extracorporeal life support (VA ECLS) therapy. While there exist reports of cases that have demonstrated the potential use of ECLS in burn patients with cardiogenic shock or acute respiratory distress syndrome, this is a unique case of VA ECLS use for an electrical injury patient who developed mixed distributive–obstructive shock secondary to pulmonary embolism and sepsis. Given the wide variety of morbidities that can result from electrical burns, VA ECLS is a promising tool for those who require cardiopulmonary support refractory to traditional measures. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
162. New Treatment Modality for Burn Injury-Related Acute Respiratory Distress Syndrome: High-Flow Nasal Oxygen Therapy in Major Burns.
- Author
-
Akın, Merve, Tuncer, Huriye Bilge, Akgün, Ali Emre, and Erkılıç, Ezgi
- Subjects
ADULT respiratory distress syndrome ,RESPIRATORY insufficiency ,INHALATION injuries ,BURN patients ,OXYGEN therapy - Abstract
Pulmonary insufficiency is the primary cause of death in cases of major burns accompanied by inhalation damage. It is important to consider the impact on the face and neck in flame burns. Early implementation of bronchial hygiene measures and oxygenation treatment in inhalation injury can reduce mortality. This case series presents the effects of high-flow nasal oxygen (HFNO) application on patient outcomes in major burns and inhalation injury. This report discusses 3 different patients. One patient, a 29-year-old male with 35% TBSA burns, received HFNO treatment for inhalation injury on the sixth day after the trauma. After 72 hours of HFNO application, the patient's pulmonary symptoms improved. The second patient had 60% TBSA burns and developed respiratory distress symptoms on the fifth day after the trauma. After 7 days of HFNO application, all symptoms and findings of acute respiratory distress syndrome (ARDS) were resolved. HFNO has been used for the treatment of ARDS related to major burn (60% of burned TBSA) in a 28-year-old patient, and improvement was achieved. The use of HFNO in pulmonary insufficiency among burn patients has not been reported previously. This series of patient cases demonstrates the successful application of HFNO in treating inhalation injury and burn-related ARDS. However, further clinical studies are necessary to increase its clinical utilization. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
163. RNA N6-methyladenosine methylation in influenza A virus infection.
- Author
-
Xueer Liu, Weiqiang Chen, Kangsheng Li, and Jiangtao Sheng
- Subjects
RNA methylation ,INFLUENZA A virus ,VIRUS diseases ,INFLUENZA viruses ,ADULT respiratory distress syndrome ,RNA viruses - Abstract
Influenza A virus (IAV) is a negative-sense single-stranded RNA virus that causes acute lung injury and acute respiratory distress syndrome, posing a serious threat to both animal and human health. N6-methyladenosine (m
6 A), a prevalent and abundant post-transcriptional methylation of RNA in eukaryotes, plays a crucial regulatory role in IAV infection by altering viral RNA and cellular transcripts to affect viral infection and the host immune response. This review focuses on the molecular mechanisms underlying m6 A modification and its regulatory function in the context of IAV infection and the host immune response. This will provide a better understanding of virus-host interactions and offer insights into potential anti-IAV strategies. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
164. Evaluation of the Prognosis of Patients With Acute Respiratory Distress Syndrome at the Emergency Department Based on the Lung Ultrasound Score.
- Author
-
Altuğ, Ertuğrul, Toksul, İbrahim Halil, Çakir, Adem, Şener, Kemal, Korkut, Semih, Kapci, Mücahit, and Güven, Ramazan
- Subjects
LUNGS ,ADULT respiratory distress syndrome ,HOSPITAL emergency services ,PROGNOSIS ,ULTRASONIC imaging ,SONICATION - Abstract
Objectives: Acute respiratory distress syndrome (ARDS) is a respiratory disease characterized by a high rate of mortality. Determining the prognosis of this disease is therefore important. Lung ultrasonography has found increased use, especially in the recent years. This study aimed to score patients diagnosed with ARDS at the emergency department using point‐of‐care ultrasound (POCUS)‐Lung and to investigate the prognosis of patients with ARDS using a scoring system. Methods: This study was designed as a single‐center prospective study. The study was performed in patients admitted to the emergency department and were diagnosed with ARDS pursuant to the Berlin criteria for ARDS and who met the inclusion criteria. The patients underwent lung ultrasonography at the emergency department and were scored (A line: 0; B1 line: 1; B2 line: 2; and C line: 3 points) accordingly. Results: The study included 100 patients with ARDS. The mortality rate was 52% in the patients in the study. The lung ultrasonography score in the mortality group (25.48 ± 3.64) was higher than that in the survivors (8.46 ± 3.61). For a cut‐off value of 17.5 for the lung ultrasonography score, the sensitivity and specificity with regard to mortality indicators were 92.8% and 90.9%, respectively (the area under the curve: 0.901; 95% confidence interval: 0.945–0.985: P <.001). Conclusion: The findings suggested that scoring based on POCUS‐Lung at the time of initial presentation at the emergency department in patients diagnosed with ARDS according to the Berlin criteria could help determine the prognosis. As POCUS‐Lung proved to be an important imaging method in investigating the affected alveolar capacity, we recommend its possible use as a prognostic indicator. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
165. Targeting the AMPK/Nrf2 Pathway: A Novel Therapeutic Approach for Acute Lung Injury.
- Author
-
Huang, Qianxia, Ren, Yingcong, Yuan, Ping, Huang, Ma, Liu, Guoyue, Shi, Yuanzhi, Jia, Guiyang, and Chen, Miao
- Subjects
NUCLEAR factor E2 related factor ,TRANSCRIPTION factors ,ADULT respiratory distress syndrome ,AMP-activated protein kinases ,APOPTOSIS ,SERINE/THREONINE kinases ,PROTEIN kinases - Abstract
ALI(acute lung injury) is a severe respiratory dysfunction caused by various intrapulmonary and extrapulmonary factors. It is primarily characterized by oxidative stress and affects the integrity of the pulmonary barrier. In severe cases, ALI can progress to ARDS(acute respiratory distress syndrome), a condition that poses a serious threat to the lives of affected patients. To date, the etiological mechanisms underlying ALI remain elusive, and available therapeutic options are quite limited. AMPK(AMP-activated protein kinase), an essential serine/threonine protein kinase, performs a pivotal function in the regulation of cellular energy levels and cellular regulatory mechanisms, including the detection of redox signals and mitigating oxidative stress. Meanwhile, Nrf2(nuclear factor erythroid 2-related factor 2), a critical transcription factor, alleviates inflammation and oxidative responses by interacting with multiple signaling pathways and contributing to the modulation of oxidative enzymes associated with inflammation and programmed cell death. Indeed, AMPK induces the dissociation of Nrf2 from Keap1(kelch-like ECH-associated protein-1) and facilitates its translocation into the nucleus to trigger the transcription of downstream antioxidant genes, ultimately suppressing the expression of inflammatory cells in the lungs. Given their roles, AMPK and Nrf2 hold promise as novel treatment targets for ALI. This study aimed to summarise the current status of research on the AMPK/Nrf2 signaling pathway in ALI, encompassing recently reported natural compounds and drugs that can activate the AMPK/Nrf2 signaling pathway to alleviate lung injury, and provide a theoretical reference for early intervention in lung injury and future research on lung protection. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
166. Management of Respiratory Failure in Hemorrhagic Shock.
- Author
-
Davis, Joshua A., Manoach, Seth, Heerdt, Paul, and Berlin, David A.
- Subjects
HEMORRHAGIC shock ,RESPIRATORY insufficiency ,ADULT respiratory distress syndrome ,POSITIVE pressure ventilation ,ARTIFICIAL respiration - Abstract
Hemorrhagic shock results in acute respiratory failure due to respiratory muscle fatigue and inadequate pulmonary blood flow. Because positive pressure ventilation can reduce venous return and cardiac output, clinicians should use the minimum possible mean airway pressure during assisted or mechanical ventilation, particularly during episodes of severe hypovolemia. Hypoperfusion also worsens dead space fraction. Therefore, clinicians should monitor capnography during mechanical ventilation and recognize that hypercapnia may be treated with fluid resuscitation rather than increasing minute ventilation. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
167. Prognostic value of interleukin‐6 serum levels in hospitalized COVID‐19 patients: A case—control study in Iran.
- Author
-
Shojaee, Asiyeh, Rafiee, Reza, Hosseinzadeh, Masoud, and Saboori, Mohamad
- Subjects
COVID-19 ,PROGNOSIS ,COVID-19 pandemic ,ADULT respiratory distress syndrome ,HOSPITAL patients - Abstract
Introduction: The coronavirus pandemic (COVID‐19) is an infectious disease with a high mortality rate that is challenging to treat. Cytokine storm is a crucial factor leading to acute respiratory distress syndrome in COVID‐19 patients. Identifying factors that predict the severity of the disease may be primarily prognostic to guide drug therapy. The objective of this study was to investigate the prognostic role of interleukin 6 (IL‐6) in the hospitalized patients infected with COVID‐19. Methods: This case‐control study was conducted from October 2019 to April 2020 at Shahid Faqihi hospital in Iran. Fifty hospitalized COVID‐19 patients and 50 healthy individuals were included while controlling demographics and comorbidities. IL‐6 serum levels were measured and compared based on demographic characteristics (age, sex) and comorbidities in the case and control groups. Spearman rank correlation coefficient was also used to analyze the correlations between IL‐6 levels and lung involvement in COVID‐19 patients. Moreover, some laboratory parameters were compared based on the percentage of lung involvement. Results: The level of IL‐6 in the case group was significantly higher than the control (p ˂ 0.001). We observed a positive and significant correlation between the level of IL‐6 and the severity of lung involvement (r = 0.0.79, p < 0.01). The median level of IL‐6 in patients who showed more than 75% lung involvement was 573 (IQR = 320−850). Conclusion: Available evidence suggests that high levels of IL‐6 are associated with the severity of COVID‐19. According to the results, it could be proposed that inhibition of IL‐6 might be a target for therapeutic managements to reduce mortality in the patients with COVID‐19. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
168. Host Innate Antiviral Response to Influenza A Virus Infection: From Viral Sensing to Antagonism and Escape.
- Author
-
An, Wenlong, Lakhina, Simran, Leong, Jessica, Rawat, Kartik, and Husain, Matloob
- Subjects
PATHOLOGY ,VIRUS diseases ,ADULT respiratory distress syndrome ,INFLUENZA A virus ,INFLUENZA viruses - Abstract
Influenza virus possesses an RNA genome of single-stranded, negative-sensed, and segmented configuration. Influenza virus causes an acute respiratory disease, commonly known as the "flu" in humans. In some individuals, flu can lead to pneumonia and acute respiratory distress syndrome. Influenza A virus (IAV) is the most significant because it causes recurring seasonal epidemics, occasional pandemics, and zoonotic outbreaks in human populations, globally. The host innate immune response to IAV infection plays a critical role in sensing, preventing, and clearing the infection as well as in flu disease pathology. Host cells sense IAV infection through multiple receptors and mechanisms, which culminate in the induction of a concerted innate antiviral response and the creation of an antiviral state, which inhibits and clears the infection from host cells. However, IAV antagonizes and escapes many steps of the innate antiviral response by different mechanisms. Herein, we review those host and viral mechanisms. This review covers most aspects of the host innate immune response, i.e., (1) the sensing of incoming virus particles, (2) the activation of downstream innate antiviral signaling pathways, (3) the expression of interferon-stimulated genes, (4) and viral antagonism and escape. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
169. COVID-19 Related Acute Respiratory Distress Syndrome versus Classical Acute Respiratory Distress Syndrome Patients: Inflammatory Biomarkers as Predictors of Mortality in Pulmonary Septic Shock.
- Author
-
Trebuian, Cosmin Iosif, Popa, Daian, Buleu, Florina, Sutoi, Dumitru, Williams, Carmen Gabriela, Crintea, Iulia Najette, Chioibas, Raul Daniel, Iancu, Aida, Ciolac, Livia, and Mederle, Ovidiu Alexandru
- Subjects
ADULT respiratory distress syndrome ,SEPTIC shock ,HOSPITAL mortality ,INTENSIVE care units ,C-reactive protein - Abstract
Objectives: Coronavirus disease-2019 (COVID-19)-related severe acute respiratory distress syndrome (ARDS) differs pathophysiological from other pulmonary septic shock-related ARDS. Thus, we assessed whether all-cause in-hospital mortality differs for severe COVID-19-related and classical severe ARDS and which inflammatory biomarkers can predict mortality among these patients. Material and Methods: This single-center, retrospective, observational cohort study included pulmonary septic shock patients (n = 114) with COVID-19-related and classical severe ARDS admitted in the Intensive Care Unit. Results: Patients with a mean age of 73 (IQR 62– 82), predominantly male (63%), were divided into two groups based on outcomes: survivors (n = 50) and non-survivors (n = 64). COVID-19-related severe ARDS (n = 48) accounts for 75% of deaths. Present comorbidities like heart disease (p = 0.043), neurologic disorders (p = 0.018), and liver disease (p = 0.038) were associated with in-hospital mortality, as well. Regarding inflammatory biomarkers, the AUC/c-statistic was 0.656 (95% CI: 0.53– 0.759) for leukocytes, 0.613 (95% CI: 0.509– 0.717) C-reactive protein (CRP) and 0.651 (95% CI: 0.548– 0.753) for procalcitonin in predicting all-cause in-hospital mortality among patients with pulmonary septic shock and severe ARDS. Conclusion: Patients with pulmonary septic shock and with COVID-19-related severe ARDS had a higher incidence of in-hospital mortality than those with classical severe ARDS. The high value of leukocytes, C-reactive protein, and procalcitonin were predictive for all-cause in-hospital mortality in patients with pulmonary septic shock and ARDS. Infection with COVID-19 was an independent predictor of in-hospital mortality in the presence of ARDS. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
170. Hydroxychloroquine attenuates sepsis-induced acute respiratory distress syndrome in rats.
- Author
-
Ercan, Gulcin, Bora, Ejder Saylav, Çınaroğlu, Osman Sezer, Karaali, Rezan, and Erbas, Oytun
- Subjects
HYDROXYCHLOROQUINE ,BIOLOGICAL models ,OXYGEN saturation ,BLOOD gases analysis ,ADULT respiratory distress syndrome ,EDEMA ,TREATMENT effectiveness ,CYTOCHEMISTRY ,RATS ,LIPID peroxidation (Biology) ,SEPSIS ,ANIMAL experimentation ,LACTIC acid ,INFLAMMATION ,HEMORRHAGE ,MALONDIALDEHYDE ,TUMOR necrosis factors ,INTERLEUKINS ,PHARMACODYNAMICS ,DISEASE complications - Abstract
Copyright of Turkish Journal of Trauma & Emergency Surgery / Ulusal Travma ve Acil Cerrahi Dergisi is the property of KARE Publishing and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2024
- Full Text
- View/download PDF
171. Safety and Efficacy of USB002 for Respiratory Distress Due to COVID-19
- Published
- 2023
172. Research on the global trends of COVID-19 associated acute kidney injury: a bibliometric analysis.
- Author
-
Zhao, Wen-jing, Tan, Rui-zhi, Gao, Jing, Su, Hongwei, Wang, Li, and Liu, Jian
- Subjects
- *
COVID-19 pandemic , *BIBLIOMETRICS , *ACUTE kidney failure , *ADULT respiratory distress syndrome , *CHRONIC kidney failure - Abstract
Critically ill COVID-19 patients may exhibit various clinical symptoms of renal dysfunction including severe Acute Kidney Injury (AKI). Currently, there is a lack of bibliometric analyses on COVID-19-related AKI. The aim of this study is to provide an overview of the current research status and hot topics regarding COVID-19 AKI. The literature was retrieved from the Web of Science Core Collection (WoSCC) database. Subsequently, we utilized Microsoft Excel, VOSviewer, Citespace, and Pajek software to revealed the current research status, emerging topics, and developmental trends pertaining to COVID-19 AKI. This study encompassed a total of 1507 studies on COVID-19 AKI. The United States, China, and Italy emerged as the leading three countries in terms of publication numbers, contributing 498 (33.05%), 229 (15.20%), and 140 (9.29%) studies, respectively. The three most active and influential institutions include Huazhong University of Science and Technology, Wuhan University and Harvard Medical School. Ronco C from Italy, holds the record for the highest number of publications, with a total of 15 papers authored. Cheng YC's work from China has garnered the highest number of citations, totaling 470 citations. The co-occurrence analysis of author keywords reveals that 'mortality', 'intensive care units', 'chronic kidney disease', 'nephrology', 'renal transplantation', 'acute respiratory distress syndrome', and 'risk factors' emerge as the primary areas of focus within the realm of COVID-19 AKI. In summary, this study analyzes the research trends in the field of COVID-19 AKI, providing a reference for further exploration and research on COVID-19 AKI mechanisms and treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
173. Research progress of megakaryocytes and platelets in lung injury.
- Author
-
Tianzhen Hua, Guangliang Zhang, Yi Yao, Haoran Jia, and Wei Liu
- Subjects
ADULT respiratory distress syndrome ,LUNG injuries ,MEGAKARYOCYTES ,BLOOD platelets ,DISEASE progression - Abstract
The lung is an important site of extramedullary platelet formation, and megakaryocytes in the lung participate in immune responses in addition to platelet production. In acute lung injury and chronic lung injury, megakaryocytes and platelets play a promoting or protective role through different mechanisms. The authors reviewed the role of megakaryocytes and platelets in common clinical lung injuries with different course of disease and different pathogenic factors in order to provide new thinking for the diagnosis and treatment of lung injuries. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
174. The Study of Correlation Between Acute Respiratory Infections and Oil Mills Pollution in Fez Rural (Morocco).
- Author
-
Essahale, Adil, Benbaqqal, Hicham, Karrouch, lahcen, and Moumni, Mohieddine
- Subjects
ADULT respiratory distress syndrome ,OIL mills ,AIR pollution ,MULTIPLE correspondence analysis (Statistics) ,AIR quality - Abstract
In order to evaluate the impact of olive activities on the population health in Fez rural, which is affected by air pollution, a retrospective study of acute respiratory infections (ARI) and chronic was studied (about ten years) in the commune of Ain Taoujdate (30 km of Fez center), known by its strong pollution particularly that of the air caused by industrial activity. Method using was the examination of medical records from 2004 to 2015. Analyzing the evolution of respiratory infections at Ain Taoujdate, we noticed a remarkable and repetitive increase, during olive tree campaign and in the spring (in each year), following the air pollution in the commune and abundance of pollen (pollinosis). Very high cases of pneumopathies recorded during the month of December 2004 and which reached 305 and 124 cases successively and which corresponds to the most important triturating activity during these twelve years of study. On the other hand the asthma crisis of Ain Taoujdate, shows a very large value in olive oil milling season. The main cause seems to be air pollution of Ain Taoujdate, since a large oil mill that releases a huge amount of fume is installed close to the population. Statistical analyzes using principal component analysis (PCA) and ascending hierarchical classification (HAC), were able to show an eventual correlation. This work excludes microbial infections; its limitation is the absence of air quality data and was the consequences to take stock of the impact of air pollution caused by oil mills on respiratory health. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
175. Cerebral Microbleeds in Critically Ill Patients with Respiratory Failure or Sepsis: A Scoping Review.
- Author
-
Chen, Bing Yu, Dang, Johnny, Cho, Sung-Min, Harnegie, Mary Pat, and Uchino, Ken
- Subjects
- *
ADULT respiratory distress syndrome , *RESPIRATORY distress syndrome , *COVID-19 , *MAGNETIC resonance imaging , *RESPIRATORY insufficiency - Abstract
Background: Cerebral microbleeds (CMBs) have been described in critically ill patients with respiratory failure, acute respiratory distress syndrome (ARDS), or sepsis. This scoping review aimed to systematically summarize existing literature on critical illness–associated CMBs. Methods: Studies reporting on adults admitted to the intensive care unit for respiratory failure, ARDS, or sepsis with evidence of CMBs on magnetic resonance imaging were included for review following a systematic search across five databases (MEDLINE, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), Scopus, and Web of Science) and a two-stage screening process. Studies were excluded if patients' CMBs were clearly explained by another process of neurological injury. Results: Forty-eight studies reporting on 216 critically ill patients (mean age 57.9, 18.4% female) with CMBs were included. Of 216, 197 (91.2%) patients developed respiratory failure or ARDS, five (2.3%) patients developed sepsis, and 14 (6.5%) patients developed both respiratory failure and sepsis. Of 211 patients with respiratory failure, 160 (75.8%) patients had coronavirus disease 2019. The prevalence of CMBs among critically ill patients with respiratory failure or ARDS was 30.0% (111 of 370 patients in cohort studies). The corpus callosum and juxtacortical area were the most frequently involved sites for CMBs (64.8% and 41.7% of all 216 patients, respectively). Functional outcomes were only reported in 48 patients, among whom 31 (64.6%) were independent at discharge, four (8.3%) were dependent at discharge, and 13 (27.1%) did not survive until discharge. Cognitive outcomes were only reported in 11 of 216 patients (5.1%), all of whom showed cognitive deficits (nine patients with executive dysfunction and two patients with memory deficits). Conclusions: Cerebral microbleeds are commonly reported in patients with critical illness due to respiratory failure, ARDS, or sepsis. CMBs had a predilection for the corpus callosum and juxtacortical area, which may be specific to critical illness–associated CMBs. Functional and cognitive outcomes of these lesions are largely unknown. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
176. Musculoskeletal manifestations of COVID-19.
- Author
-
da Silva, Lucas N. M., Filho, Alípio Gomes Ormond, and Guimarães, Júlio Brandão
- Subjects
- *
SARS-CoV-2 , *POST-acute COVID-19 syndrome , *COVID-19 pandemic , *COVID-19 , *ADULT respiratory distress syndrome - Abstract
During the COVID-19 pandemic, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected millions of people worldwide, with acute respiratory distress syndrome (ARDS) being the most common severe condition of pulmonary involvement. Despite its involvement in the lungs, SARS-CoV-2 causes multiple extrapulmonary manifestations, including manifestations in the musculoskeletal system. Several cases involving bone, joint, muscle, neurovascular and soft tissues were reported shortly after pandemic onset. Even after the acute infection has resolved, many patients experience persistent symptoms and a decrease in quality of life, a condition known as post-COVID syndrome or long COVID. COVID-19 vaccines have been widely available since December 2020, preventing millions of deaths during the pandemic. However, adverse reactions, including those involving the musculoskeletal system, have been reported in the literature. Therefore, the primary goal of this article is to review the main imaging findings of SARS-CoV-2 involvement in the musculoskeletal system, including acute, subacute, chronic and postvaccination manifestations. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
177. Effect of a biomimetic pathogen adsorbing device on inflammatory biomarkers in COVID‐19 patients.
- Author
-
Schmieszek, Jan, Fuehner, Thomas, Renger, Isabelle, Welte, Tobias, Menne, Jan, Fuge, Jan, van't Klooster, Maria P., Paul, Andrea, Siegert, Alina, Borchina, Dan‐Nicolae, Falk, Christine S., and Kielstein, Jan T.
- Subjects
ADULT respiratory distress syndrome ,BIOMARKERS ,HEMOGLOBINS ,TOXINS - Abstract
Introduction: The Seraph 100 Microbind Affinity blood filter eliminate bacteria, viruses, fungi and toxins from blood stream. Methods: This is a prospective multicenter observational biomarker trial in PCR‐positive SARS‐CoV‐2 patients with acute respiratory failure. Biomarkers were sequentially tested at three time points. Results: Forty‐two patients with SARS‐CoV‐2 detected by PCR with acute respiratory failure were included. When receiving hemoperfusion treatment, 27 (64%) patients were on mechanical ventilation, 41 (98%) patients were treated in the ICU. The 3‐month survival was 52%. After one hemoperfusion treatment cycle, D‐dimer (p = 0.014), hemoglobin (p = 0.003) and LDH (p = 0.001) concentrations were significantly reduced 4 days after treatment. From the multiplex assay IL‐1b, CXCL8/ IL‐8, IL‐10, IL‐13, IL‐15, CCL11/Eotaxin, G‐CSF, and CXCL10/IP‐10 were significantly reduced 1 h after treatment, however not 4 days later. Conclusion: Hemoperfusion with Seraph 100 Microbind Affinity Filter in patients with severe COVID‐19 can transiently reduce several inflammatory biomarkers in the blood. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
178. Racial disparities in utilization of ECMO in COVID-19 patients: a retrospective population-based analysis
- Author
-
Mohannad Al Akeel, Jefferson Thompson, Shahnawaz Notta, Jeetendra Patel, and Mahmoud Abdelghany
- Subjects
critical care ,adult respiratory distress syndrome ,mechanical circulatory support ,ecmo ,covid. ,Medical emergencies. Critical care. Intensive care. First aid ,RC86-88.9 - Abstract
INTRODUCTION: Extracorporeal membrane oxygenation (ECMO) is a crucial intervention for severe respiratory failure, including in cases of COVID-19. Medical research has shown disparities in multiple fields of healthcare as well as in the utilisation of ECMO. Racial disparities in the utilisation of ECMO among COVID-19 patients are a concern, which requires investigation to ensure equitable access to life-saving treatments. To our knowledge, no study that have specifically evaluated the utilisation of ECMO among COVID-19 patients. Our aim from this study is to explore racial disparities in healthcare care, and specifically in the use of ECMO. The objective of the study was to evaluate any possible disparities that exist in the odds of receiving ECMO based on race after correcting for other confounding factors in patients admitted with COVID-19 pneumonia. MATERIALS AND METHODS: This retrospective study analysed data from the National Inpatient Sample (NIS) database spanning 2019 to 2020. A total of 1,507,585 admissions for COVID-19 pneumonia were examined, of which 3,070 required ECMO. Statistical analyses, including adjusted odds ratios and multivariate logistic regression models, were employed to assess the association between race and ECMO utilisation using STATA 17 version RESULTS: The mean age of the studied population was 48.85 with a standard deviation of 0.5. 1075 white patients have utilized the ECMO when admitted to the hospital, compared to 605 black patients, 1055 Hispanics, 90 Asians, 75 Native Americans and 170 patients in ‘Others’ race group. Adjusted odds ratios for receiving ECMO, compared to Whites as the reference group, did not reveal statistically significant differences for African Americans (OR 1.03; 95% CI 0.75 - 1.40; P value = 0.86) and Asians (OR 1.04; 95% CI 0.75 - 1.75; P value = 0.86). Hispanics showed a significantly higher probability of receiving ECMO (OR 1.32; 95% CI 1.01 - 1.73; P-value=0.04), as did Native Americans (OR 2.16; 95% CI 1.18 - 3.94; P-value=0.012). CONCLUSIONS: Addressing disparities in ECMO utilisation is crucial to ensure equitable access to lifesaving interventions among COVID-19 patients. Strategies to mitigate racial disparities in healthcare access and treatment are essential to optimise patient outcomes and fostering health equity.
- Published
- 2024
- Full Text
- View/download PDF
179. Laboratory findings predictive of critical illness in hospitalized COVID-19 patients in Tunisia [version 1; peer review: awaiting peer review]
- Author
-
Donia Belkhir, Hana Blibech, Line Kaabi, Saoussen Miladi, Mohamed Aymen Jebali, Jalloul Daghfous, Nadia Mehiri, Ahmed Laatar, Nozha Ben Salah, Houda Snene, and Bechir Louzir
- Subjects
Research Article ,Articles ,COVID-19 ,Viral pneumonia ,Critical illness ,Adult respiratory distress syndrome ,Biomarkers ,Prognosis - Abstract
Background COVID-19 disease has spread rapidly worldwide, causing high mortality. Accessible biomarkers capable of early identification of patients at risk of severe form are needed in clinical practice. The aim of the study was to determine the biological markers that predict a critical condition. Methods Retrospective study including patients with confirmed COVID-19 hospitalized between September 2020 and June 2021. The primary endpoint was progression to critical status within 7 days from admission. We defined two groups: Critical group: Patients who developed a critical condition or died or transferred to the ICU before or at 7 th day. Non-critical group: Patients who remained in non-critical respiratory status until 7 th day or discharged before or at 7 th day. Results Our study included 456 patients, with a sex ratio of 1.32 and an average age of 62 years. At the 7 th day of hospitalization, 115 (25.2%) patients were in the critical group and 341 (74.8%) patients were in the non-critical group. The univariate logistic regression indicated that laboratory findings between non-critical and critical groups showed that C-reactive protein (CRP) (p=0.047), D-Dimer (p=0.011), creatinine (0.026), creatine kinase (p=0.039), lactate dehydrogenase (p=0.04), and troponin (p=0.001) were all higher among patients in critical group. However, lymphocyte (p71.5 (OR=1.598, 95% CI=1.042-2.45, p=0.032) were associated to critical group. Conclusions Our results show the predictive value of some biological markers to evaluate the prognosis of COVID-19 pneumonia. A prognostic score could be proposed for guiding clinical care and improving patient outcomes.
- Published
- 2024
- Full Text
- View/download PDF
180. ECMO is associated with decreased hospital mortality in COVID-19 ARDS.
- Author
-
Kim, Won-Young, Jung, Sun-Young, Kim, Jeong-Yeon, Chae, Ganghee, Kim, Junghyun, Joh, Joon-Sung, Park, Tae Yun, Baek, Ae-Rin, Jegal, Yangjin, Chung, Chi Ryang, Lee, Jinwoo, Cho, Young-Jae, Park, Joo Hun, Hwang, Jung Hwa, and Song, Jin Woo
- Subjects
- *
HOSPITAL mortality , *COVID-19 , *ADULT respiratory distress syndrome , *EXTRACORPOREAL membrane oxygenation , *PATIENT positioning - Abstract
This study determined whether compared to conventional mechanical ventilation (MV), extracorporeal membrane oxygenation (ECMO) is associated with decreased hospital mortality or fibrotic changes in patients with COVID-19 acute respiratory distress syndrome. A cohort of 72 patients treated with ECMO and 390 with conventional MV were analyzed (February 2020–December 2021). A target trial was emulated comparing the treatment strategies of initiating ECMO vs no ECMO within 7 days of MV in patients with a PaO2/FiO2 < 80 or a PaCO2 ≥ 60 mmHg. A total of 222 patients met the eligibility criteria for the emulated trial, among whom 42 initiated ECMO. ECMO was associated with a lower risk of hospital mortality (hazard ratio [HR], 0.56; 95% confidence interval [CI] 0.36–0.96). The risk was lower in patients who were younger (age < 70 years), had less comorbidities (Charlson comorbidity index < 2), underwent prone positioning before ECMO, and had driving pressures ≥ 15 cmH2O at inclusion. Furthermore, ECMO was associated with a lower risk of fibrotic changes (HR, 0.30; 95% CI 0.11–0.70). However, the finding was limited due to relatively small number of patients and differences in observability between the ECMO and conventional MV groups. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
181. Correlation between normally aerated lung and respiratory system compliance at clinical high positive end-expiratory pressure in patients with COVID-19.
- Author
-
Ogura, Keishi, Nakayama, Ryuichi, Bunya, Naofumi, Katayama, Shinshu, Yama, Naoya, Goto, Yuya, Sawamoto, Keigo, Uemura, Shuji, and Narimatsu, Eichi
- Subjects
- *
LUNGS , *POSITIVE end-expiratory pressure , *COVID-19 , *RESPIRATORY organs , *ADULT respiratory distress syndrome , *LUNG volume - Abstract
Normally aerated lung tissue on computed tomography (CT) is correlated with static respiratory system compliance (Crs) at zero end-expiratory pressure. In clinical practice, however, patients with acute respiratory failure are often managed using elevated PEEP levels. No study has validated the relationship between lung volume and tissue and Crs at the applied positive end-expiratory pressure (PEEP). Therefore, this study aimed to demonstrate the relationship between lung volume and tissue on CT and Crs during the application of PEEP for the clinical management of patients with acute respiratory distress syndrome due to COVID-19. Additionally, as a secondary outcome, the study aimed to evaluate the relationship between CT characteristics and Crs, considering recruitability using the recruitment-to-inflation ratio (R/I ratio). We analyzed the CT and respiratory mechanics data of 30 patients with COVID-19 who were mechanically ventilated. The CT images were acquired during mechanical ventilation at PEEP level of 15 cmH2O and were quantitatively analyzed using Synapse Vincent system version 6.4 (Fujifilm Corporation, Tokyo, Japan). Recruitability was stratified into two groups, high and low recruitability, based on the median R/I ratio of our study population. Thirty patients were included in the analysis with the median R/I ratio of 0.71. A significant correlation was observed between Crs at the applied PEEP (median 15 [interquartile range (IQR) 12.2, 15.8]) and the normally aerated lung volume (r = 0.70 [95% CI 0.46–0.85], P < 0.001) and tissue (r = 0.70 [95% CI 0.46–0.85], P < 0.001). Multivariable linear regression revealed that recruitability (Coefficient = − 390.9 [95% CI − 725.0 to − 56.8], P = 0.024) and Crs (Coefficient = 48.9 [95% CI 32.6–65.2], P < 0.001) were significantly associated with normally aerated lung volume (R-squared: 0.58). In this study, Crs at the applied PEEP was significantly correlated with normally aerated lung volume and tissue on CT. Moreover, recruitability indicated by the R/I ratio and Crs were significantly associated with the normally aerated lung volume. This research underscores the significance of Crs at the applied PEEP as a bedside-measurable parameter and sheds new light on the link between recruitability and normally aerated lung. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
182. Impact of intensive prone position therapy on outcomes in intubated patients with ARDS related to COVID-19.
- Author
-
Le Terrier, Christophe, Walter, Thaïs, Lebbah, Said, Hajage, David, Sigaud, Florian, Guérin, Claude, Desmedt, Luc, Primmaz, Steve, Jousselin, Vincent, Della Badia, Chiara, Ricard, Jean-Damien, Pugin, Jérôme, Terzi, Nicolas, COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators, Mercat, Alain, Asfar, Pierre, Beloncle, François, Demiselle, Julien, Pham, Tài, and Pavot, Arthur
- Subjects
- *
ADULT respiratory distress syndrome , *CRITICALLY ill , *PATIENTS , *T-test (Statistics) , *LYING down position , *FISHER exact test , *TREATMENT duration , *TREATMENT effectiveness , *REVERSE transcriptase polymerase chain reaction , *MANN Whitney U Test , *DESCRIPTIVE statistics , *LONGITUDINAL method , *INTENSIVE care units , *RESEARCH , *SURVIVAL analysis (Biometry) , *CONFIDENCE intervals , *COVID-19 - Abstract
Background: Previous retrospective research has shown that maintaining prone positioning (PP) for an average of 40 h is associated with an increase of survival rates in intubated patients with COVID-19-related acute respiratory distress syndrome (ARDS). This study aims to determine whether a cumulative PP duration of more than 32 h during the first 2 days of intensive care unit (ICU) admission is associated with increased survival compared to a cumulative PP duration of 32 h or less. Methods: This study is an ancillary analysis from a previous large international observational study involving intubated patients placed in PP in the first 48 h of ICU admission in 149 ICUs across France, Belgium and Switzerland. Given that PP is recommended for a 16-h daily duration, intensive PP was defined as a cumulated duration of more than 32 h during the first 48 h, whereas standard PP was defined as a duration equal to or less than 32 h. Patients were followed-up for 90 days. The primary outcome was mortality at day 60. An Inverse Probability Censoring Weighting (IPCW) Cox model including a target emulation trial method was used to analyze the data. Results: Out of 2137 intubated patients, 753 were placed in PP during the first 48 h of ICU admission. The intensive PP group (n = 79) had a median PP duration of 36 h, while standard PP group (n = 674) had a median of 16 h during the first 48 h. Sixty-day mortality rate in the intensive PP group was 39.2% compared to 38.7% in the standard PP group (p = 0.93). Twenty-eight-day and 90-day mortality as well as the ventilator-free days until day 28 were similar in both groups. After IPCW, there was no significant difference in mortality at day 60 between the two-study groups (HR 0.95 [0.52–1.74], p = 0.87 and HR 1.1 [0.77–1.57], p = 0.61 in complete case analysis or in multiple imputation analysis, respectively). Conclusions: This secondary analysis of a large multicenter European cohort of intubated patients with ARDS due to COVID-19 found that intensive PP during the first 48 h did not provide a survival benefit compared to standard PP. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
183. Sivelestat improves acute lung injury by inhibiting PI3K/AKT/mTOR signaling pathway.
- Author
-
Zhou, Yaqing, Wang, Haiyan, Liu, Aiming, Pu, Zunguo, Ji, Qiuxia, Xu, Jianhua, Xu, Yuehua, and Wang, Ying
- Subjects
- *
LUNGS , *REVERSE transcriptase polymerase chain reaction , *LUNG injuries , *ADULT respiratory distress syndrome , *CELLULAR signal transduction , *LABORATORY rats - Abstract
Objective: To investigate the therapeutic effect and mechanism of sivelestat sodium on acute lung injury (AIL). Methods: A rat model for ALI/acute respiratory distress syndrome (ALI/ARDS) was established. Pathological examination of lung tissue was conducted to assess lung injury. Blood gas in the arteries was measured using a blood analyzer. Changes in PaO2, PaO2/FiO2, and lung wet/dry (W/D) weight ratio were carefully compared. ELISA assay was conducted to estimate cell adhesion and inflammation response. Finally, real-time reverse transcription polymerase chain reaction and western blotting assay was used to determine the activation of PI3K/AKT/mTOR pathway. Results: ARDS in vivo model was successfully constructed by LPS injection. Compared with the sham group, PaO2 and PaO2/FiO2 were significantly lower in the vehicle group, while the lung W/D ratio, the lung injury score, NE, VCAM-1, IL-8 andTNF-αwere significantly increased. After treatment with different doses of sivelestat sodium, we found PaO2, PaO2/FiO2 were prominently increased, while the lung W/D ratio, the lung injury score, NE, VCAM-1, IL-8, TNF-α levels were decreased in the dose-dependent manner. Meanwhile, compared with the vehicle group, the expression levels of Bax, PI3K, Akt and mTOR were significantly lower, and the expression of Bcl-2 was significantly higher after injection with sivelestat sodium. Conclusion: Sivelestat sodium has an interventional effect on ALI in sepsis by inhibiting the PI3K/AKT/mTOR signalling pathway. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
184. SARS-CoV-2: pathogenesis, therapeutics, variants, and vaccines.
- Author
-
Xi Li, Ze Mi, Zhenguo Liu, and Pengfei Rong
- Subjects
SARS-CoV-2 ,COVID-19 ,ADULT respiratory distress syndrome - Abstract
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in December 2019 with staggering economic fallout and human suffering. The unique structure of SARS-CoV-2 and its underlying pathogenic mechanism were responsible for the global pandemic. In addition to the direct damage caused by the virus, SARS-CoV-2 triggers an abnormal immune response leading to a cytokine storm, culminating in acute respiratory distress syndrome and other fatal diseases that pose a significant challenge to clinicians. Therefore, potential treatments should focus not only on eliminating the virus but also on alleviating or controlling acute immune/inflammatory responses. Current management strategies for COVID-19 include preventative measures and supportive care, while the role of the host immune/inflammatory response in disease progression has largely been overlooked. Understanding the interaction between SARSCoV-2 and its receptors, as well as the underlying pathogenesis, has proven to be helpful for disease prevention, early recognition of disease progression, vaccine development, and interventions aimed at reducing immunopathology have been shown to reduce adverse clinical outcomes and improve prognosis. Moreover, several key mutations in the SARS-CoV-2 genome sequence result in an enhanced binding affinity to the host cell receptor, or produce immune escape, leading to either increased virus transmissibility or virulence of variants that carry these mutations. This review characterizes the structural features of SARS-CoV-2, its variants, and their interaction with the immune system, emphasizing the role of dysfunctional immune responses and cytokine storm in disease progression. Additionally, potential therapeutic options are reviewed, providing critical insights into disease management, exploring effective approaches to deal with the public health crises caused by SARSCoV-2. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
185. Nucleated red blood cells as a prognostic marker for mortality in patients with SARS-CoV-2-induced ARDS: an observational study.
- Author
-
Kirsch, Anna, Niebhagen, Felix, Goldammer, Miriam, Waske, Sandra, Heubner, Lars, Petrick, Paul, Güldner, Andreas, Koch, Thea, Spieth, Peter, and Menk, Mario
- Subjects
ERYTHROCYTES ,ADULT respiratory distress syndrome ,PROGNOSIS ,LOGISTIC regression analysis ,REGRESSION analysis - Abstract
Background: The presence of nucleated red blood cells (NRBCs) in the peripheral blood of critically ill patients is associated with poor outcome. Evidence regarding the predictive value of NRBCs in patients with SARS-CoV-2-induced acute respiratory distress syndrome (ARDS) remains elusive. The aim of this study was to evaluate the predictive validity of NRBCs in these patients. Methods: Daily NRBC values of adult patients with SARS-CoV-2-induced ARDS were assessed and their predictive validity for mortality was statistically evaluated. A cut-off level based on the patient's maximum NRBC value during ICU stay was calculated and further specified according to Youden's method. Based on this cut-off value, further analyses such as logistic regression models and survival were performed. Results: 413 critically ill patients with SARS-CoV-2-induced ARDS were analyzed. Patients who did not survive had significantly higher NRBC values during their ICU stay compared to patients who survived (1090/µl [310; 3883] vs. 140/µl [20; 500]; p < 0.0001). Patients with severe ARDS (n = 374) had significantly higher NRBC values during ICU stay compared to patients with moderate ARDS (n = 38) (490/µl [120; 1890] vs. 30/µl [10; 476]; p < 0.0001). A cut-off level of NRBC ≥ 500/µl was found to best stratify risk and was associated with a longer duration of ICU stay (12 [8; 18] vs. 18 [13; 27] days; p < 0.0001) and longer duration of mechanical ventilation (10 [6; 16] vs. 17 [12; 26] days; p < 0.0001). Logistic regression analysis with multivariate adjustment showed NRBCs ≥ 500/µl to be an independent risk factor of mortality (odds ratio (OR) 4.72; 95% confidence interval (CI) 2.95–7.62, p < 0.0001). Patients with NRBC values below the threshold of 500/µl had a significant survival advantage over those above the threshold (median survival 32 [95% CI 8.7–43.3] vs. 21 days [95% CI 18.2–23.8], log-rank test, p < 0.05). Patients who once reached the NRBC threshold of ≥ 500/µl during their ICU stay had a significantly increased long-term mortality (median survival 489 days, log-rank test, p = 0.0029, hazard ratio (HR) 3.2, 95% CI 1.2–8.5). Conclusions: NRBCs predict mortality in critically ill patients with SARS-CoV-2-induced ARDS with high prognostic power. Further studies are required to confirm the clinical impact of NRBCs to eventually enhance decision making. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
186. Infant feeding and criticality in children.
- Author
-
Sorce, Lauren R., Asaro, Lisa A., and Curley, Martha A. Q.
- Subjects
- *
CRITICALLY ill children , *ADULT respiratory distress syndrome , *PEDIATRIC nurses , *PEDIATRIC intensive care , *INTENSIVE care units , *INFANTS - Abstract
Background Aim Study design Results Conclusions Relevance to Clinical Practice Data support the protective effects of human breast milk (HBM) feeding in acute illness but little is known about the impact of HBM feeding on the criticality of infants.To explore the relationship between early HBM feeding and severity of illness and recovery in critically ill children requiring intubation and mechanical ventilation for acute respiratory failure (ARF).Prospective cohort study of mothers of patients aged 1–36 months who participated in the acute and follow‐up phases of the Randomized Evaluation of Sedation Titration for Respiratory Failure (RESTORE) clinical trial. Participants completed a survey describing HBM dose fed during their infant's first month of life.Of 138 patients, 70 (51%) received exclusive HBM feedings (90%–100% total feeds) and 68 (49%) did not. We found no group differences in severity of illness on paediatric intensive care unit (PICU) admission or severity of paediatric acute respiratory distress syndrome (PARDS) within the first 24–48 h of intubation/mechanical ventilation (Pediatric Risk of Mortality [PRISM] III‐12 score median: 5 vs. 5, p = .88; moderate/severe PARDS: 53% vs. 54%, p = .63). While median time to recovery from ARF was reduced by 1 day in patients who received exclusive HBM feedings, the difference between groups was not statistically significant (median 1.5 vs. 2.6 days, hazard ratio 1.40 [95% confidence interval, 0.99–1.97], p = .06).Human breast milk dose was not associated with severity of illness on PICU admission in children requiring mechanical ventilation for ARF.Data support the protective effects of HBM during acute illness and data from this study support a clinically important reduction in time to recovery of ARF. Paediatric nurses should continue to champion HBM feeding to advance improvements in infant health. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
187. The use of prone position ventilation in Danish patients with COVID‐19‐induced severe acute respiratory distress syndrome treated with veno‐venous extracorporeal membrane oxygenation: A nationwide cohort study with focus on pulmonary effects.
- Author
-
Jørgensen, Vibeke Lind, Adelsten, Janne, Christensen, Steffen, Nielsen, Dorthe Viemose, Eschen, Camilla Tofte, Sørensen, Hasse Møller, Sørensen, Marc, Madsen, Søren Aalbæk, Gjedsted, Jakob, Pedersen, Finn Møller, Nielsen, Jonas, and Grønlykke, Lars
- Subjects
- *
ADULT respiratory distress syndrome , *PATIENT positioning , *EXTRACORPOREAL membrane oxygenation , *DANES , *COVID-19 - Abstract
Background Methods Results Conclusion Prone position ventilation (PPV) is recommended for patients with COVID‐19 induced severe Adult Respiratory Distress Syndrome (ARDS) and is used for patients supported with V‐V ECMO as well. The purpose of this study was to describe the use of PPV in these patients focusing on physiological effects with the hypothesis that PPV could reduce oxygen need and improve dynamic compliance.This study was a nationwide retrospective analysis of all COVID‐19 patients in Denmark from March 2020 – December 2021 with severe ARDS and need of V‐V ECMO support. Data on the number of patients treated with PPV, number of PPV sessions, timing, the time spent in prone position, pulmonary physiological response types with analysis of variables affecting the response are reported.Out of 68 patients 44 were treated with 220 PPV sessions and a positive clinical response was observed in 80% of patients but only in 45% of sessions. On a single session level, increased compliance was observed in 38% and increased oxygenation in only 15% of 220 sessions, with within‐patient heterogeneity. Higher dynamic compliance at the beginning of a PPV session was associated with a lower delta change in dynamic compliance during PPV. The response to a PPV session could not be predicted by the response in the prior session. Dynamic compliance did not change during the ECMO course.Eighty percent of patients responded positively during a PPV session, but this was not associated with overall pulmonary improvement. On a single patient level, responses were heterogenous and only 45% of sessions resulted in clinical improvement. Response in dynamic compliance was associated with starting values of compliance. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
188. End-expiratory lung volumes as a potential indicator for COVID-19 associated acute respiratory distress syndrome: a retrospective study.
- Author
-
Hao, Shengyu, Wei, Yilin, Wang, Yuxian, Muhetaer, Yaxiaerjiang, Zhou, Chujun, Qiong, Songjie, Jiang, Pan, and Zhong, Ming
- Subjects
ADULT respiratory distress syndrome ,LUNG volume ,COVID-19 ,RESPIRATORY mechanics ,COMPUTED tomography - Abstract
Background: End-expiratory lung volume (EELV) has been observed to decrease in acute respiratory distress syndrome (ARDS). Yet, research investigating EELV in patients with COVID-19 associated ARDS (CARDS) remains limited. It is unclear whether EELV could serve as a potential metric for monitoring disease progression and identifying patients with ARDS at increased risk of adverse outcomes. Study design and methods: This retrospective study included mechanically ventilated patients diagnosed with CARDS during the initial phase of epidemic control in Shanghai. EELV was measured using the nitrogen washout-washin technique within 48 h post-intubation, followed by regular assessments every 3–4 days. Chest CT scans, performed within a 24-hour window around each EELV measurement, were analyzed using AI software. Differences in patient demographics, clinical data, respiratory mechanics, EELV, and chest CT findings were assessed using linear mixed models (LMM). Results: Out of the 38 patients enrolled, 26.3% survived until discharge from the ICU. In the survivor group, EELV, EELV/predicted body weight (EELV/PBW) and EELV/predicted functional residual capacity (EELV/preFRC) were significantly higher than those in the non-survivor group (survivor group vs. non-survivor group: EELV: 1455 vs. 1162 ml, P = 0.049; EELV/PBW: 24.1 vs. 18.5 ml/kg, P = 0.011; EELV/preFRC: 0.45 vs. 0.34, P = 0.005). Follow-up assessments showed a sustained elevation of EELV/PBW and EELV/preFRC among the survivors. Additionally, EELV exhibited a positive correlation with total lung volume and residual lung volume, while demonstrating a negative correlation with lesion volume determined through chest CT scans analyzed using AI software. Conclusion: EELV is a useful indicator for assessing disease severity and monitoring the prognosis of patients with CARDS. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
189. Adherence with post-hospitalization follow-up after pediatric critical illness due to respiratory failure.
- Author
-
Yagiela, Lauren M., Pfarr, Marie A., Meert, Kathleen, and Odetola, Fola O.
- Subjects
RESPIRATORY insufficiency ,CRITICALLY ill ,ADULT respiratory distress syndrome ,PEDIATRIC intensive care ,INTENSIVE care units ,PATIENT discharge instructions ,RESPIRATORY therapists - Abstract
Background: Adherence with follow-up appointments after a pediatric intensive care unit (PICU) admission is likely a key component in managing post-PICU sequalae. However, prior work on PICU follow-up adherence is limited. The objective of this study is to identify hospitalization characteristics, discharge child health metrics, and follow-up characteristics associated with full adherence with recommended follow-up at a quaternary care center after a PICU admission due to respiratory failure. Methods: We conducted a retrospective cohort study of patients ≤ 18 years with respiratory failure admitted between 1/2013–12/2014 to a quaternary care PICU. Post-hospitalization full adherence with recommended follow-up in the two years post discharge (1/2013–3/2017) at the quaternary care center was quantified and compared by demographics, baseline child health metrics, hospitalization characteristics, discharge child health metrics, and follow-up characteristics in bivariate and multivariate analyses. Patients were dichotomized into being non-adherent with follow-up (patients who attended less than 100% of recommended appointments at the quaternary care center) and fully adherent (patients who attended 100% of recommended appointments at the quaternary care center). Results: Of 155 patients alive at hospital discharge, 140 (90.3%) were recommended to follow-up at the quaternary care center. Of the 140 patients with recommended follow-up at the quaternary care center, 32.1% were non-adherent with follow-up and 67.9% were fully adherent. In a multivariable logistic regression model, each additional recommended unique follow-up appointment was associated with lower odds of being fully adherent with follow-up (OR 0.74, 95% CI 0.60–0.91, p = 0.005), and each 10% increase in the proportion of appointments scheduled before discharge was associated with higher odds of being fully adherent with follow-up (OR 1.02, 95% CI 1.01–1.03, p = 0.004). Conclusions: After admission for acute respiratory failure, only two-thirds of children were fully adherent with recommended follow-up at a quaternary care center. Our findings suggest that limiting the recommended follow-up to only key essential healthcare providers and working to schedule as many appointments as possible before discharge could improve follow-up adherence. However, a better understanding of the factors that lead to non-adherence with follow-up appointments is needed to inform broader system-level approaches could help improve PICU follow-up adherence. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
190. PNSC928, a plant-derived compound, specifically disrupts CtBP2-p300 interaction and reduces inflammation in mice with acute respiratory distress syndrome.
- Author
-
Li, Fan, Yan, Wenqing, Dong, Weihua, Chen, Zhiping, and Chen, Zhi
- Subjects
- *
ADULT respiratory distress syndrome , *C-terminal binding proteins , *NF-kappa B , *HISTONE acetyltransferase , *SMALL molecules - Abstract
Background: Prior research has highlighted the involvement of a transcriptional complex comprising C-terminal binding protein 2 (CtBP2), histone acetyltransferase p300, and nuclear factor kappa B (NF-κB) in the transactivation of proinflammatory cytokine genes, contributing to inflammation in mice with acute respiratory distress syndrome (ARDS). Nonetheless, it remains uncertain whether the therapeutic targeting of the CtBP2-p300-NF-κB complex holds potential for ARDS suppression. Methods: An ARDS mouse model was established using lipopolysaccharide (LPS) exposure. RNA-Sequencing (RNA-Seq) was performed on ARDS mice and LPS-treated cells with CtBP2, p300, and p65 knockdown. Small molecules inhibiting the CtBP2-p300 interaction were identified through AlphaScreen. Gene and protein expression levels were quantified using RT-qPCR and immunoblots. Tissue damage was assessed via histological staining. Key findings: We elucidated the specific role of the CtBP2-p300-NF-κB complex in proinflammatory gene regulation. RNA-seq analysis in LPS-challenged ARDS mice and LPS-treated CtBP2-knockdown (CtBP2KD), p300KD, and p65KD cells revealed its significant impact on proinflammatory genes with minimal effects on other NF-κB targets. Commercial inhibitors for CtBP2, p300, or NF-κB exhibited moderate cytotoxicity in vitro and in vivo, affecting both proinflammatory genes and other targets. We identified a potent inhibitor, PNSC928, for the CtBP2-p300 interaction using AlphaScreen. PNSC928 treatment hindered the assembly of the CtBP2-p300-NF-κB complex, substantially downregulating proinflammatory cytokine gene expression without observable cytotoxicity in normal cells. In vivo administration of PNSC928 significantly reduced CtBP2-driven proinflammatory gene expression in ARDS mice, alleviating inflammation and lung injury, ultimately improving ARDS prognosis. Conclusion: Our results position PNSC928 as a promising therapeutic candidate to specifically target the CtBP2-p300 interaction and mitigate inflammation in ARDS management. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
191. Pathogenic mechanisms of cardiovascular damage in COVID-19.
- Author
-
Shao, Hong-Hua and Yin, Rui-Xing
- Subjects
- *
SARS-CoV-2 , *HEART failure , *EMERGING infectious diseases , *ADULT respiratory distress syndrome , *CORONARY disease - Abstract
Background: COVID-19 is a new infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS CoV-2). Since the outbreak in December 2019, it has caused an unprecedented world pandemic, leading to a global human health crisis. Although SARS CoV-2 mainly affects the lungs, causing interstitial pneumonia and severe acute respiratory distress syndrome, a number of patients often have extensive clinical manifestations, such as gastrointestinal symptoms, cardiovascular damage and renal dysfunction. Purpose: This review article discusses the pathogenic mechanisms of cardiovascular damage in COVID-19 patients and provides some useful suggestions for future clinical diagnosis, treatment and prevention. Methods: An English-language literature search was conducted in PubMed and Web of Science databases up to 12th April, 2024 for the terms "COVID-19", "SARS CoV-2", "cardiovascular damage", "myocardial injury", "myocarditis", "hypertension", "arrhythmia", "heart failure" and "coronary heart disease", especially update articles in 2023 and 2024. Salient medical literatures regarding the cardiovascular damage of COVID-19 were selected, extracted and synthesized. Results: The most common cardiovascular damage was myocarditis and pericarditis, hypertension, arrhythmia, myocardial injury and heart failure, coronary heart disease, stress cardiomyopathy, ischemic stroke, blood coagulation abnormalities, and dyslipidemia. Two important pathogenic mechanisms of the cardiovascular damage may be direct viral cytotoxicity as well as indirect hyperimmune responses of the body to SARS CoV-2 infection. Conclusions: Cardiovascular damage in COVID-19 patients is common and portends a worse prognosis. Although the underlying pathophysiological mechanisms of cardiovascular damage related to COVID-19 are not completely clear, two important pathogenic mechanisms of cardiovascular damage may be the direct damage of the SARSCoV-2 infection and the indirect hyperimmune responses. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
192. Chronic obstructive pulmonary disease affects outcome in surgical patients with perioperative organ injury: a retrospective cohort study in Germany.
- Author
-
Hochhausen, Nadine, Mechelinck, Mare, Kroh, Andreas, Rossaint, Rolf, and Kork, Felix
- Subjects
- *
CHRONIC obstructive pulmonary disease , *MYOCARDIAL infarction , *ADULT respiratory distress syndrome , *COHORT analysis , *LENGTH of stay in hospitals , *ACUTE kidney failure - Abstract
Background: The impact of chronic obstructive pulmonary disease (COPD) on outcome in perioperative organ injury (POI) has not yet been investigated sufficiently. Methods: This retrospective cohort study analysed data of surgical patients with POI, namely delirium, stroke, acute myocardial infarction, acute respiratory distress syndrome, acute liver injury (ALI), or acute kidney injury (AKI), in Germany between 2015 and 2019. We compared in-hospital mortality, hospital length of stay (HLOS) and perioperative ventilation time (VT) in patients with and without COPD. Results: We analysed the data of 1,642,377 surgical cases with POI of which 10.8% suffered from COPD. In-hospital mortality was higher (20.6% vs. 15.8%, p < 0.001) and HLOS (21 days (IQR, 12–34) vs. 16 days (IQR, 10–28), p < 0.001) and VT (199 h (IQR, 43–547) vs. 125 h (IQR, 32–379), p < 0.001) were longer in COPD patients. Within the POI examined, AKI was the most common POI (57.8%), whereas ALI was associated with the highest mortality (54.2%). Regression analysis revealed that COPD was associated with a slightly higher risk of in-hospital mortality (OR, 1.19; 95% CI:1.18–1.21) in patients with any POI. Conclusions: COPD in patients with POI is associated with higher mortality, longer HLOS and longer VT. Especially patients suffering from ALI are susceptible to the detrimental effects of COPD on adverse outcome. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
193. TM9SF1 offers utility as an efficient predictor of clinical severity and mortality among acute respiratory distress syndrome patients.
- Author
-
Fengsheng Cao, Lu Zhang, Zhenwang Zhao, Xiaofang Shen, Jinsong Xiong, Zean Yang, Baoxian Gong, Mingming Liu, Huabo Chen, Hong Xiao, Min Huang, Yang Liu, Guangyu Qiu, Ke Wang, Fengqiao Zhou, and Juan Xiao
- Subjects
ADULT respiratory distress syndrome ,MONONUCLEAR leukocytes ,CRITICALLY ill patient care ,NEUTROPHIL lymphocyte ratio ,GENE expression - Abstract
Introduction: Acute respiratory distress syndrome (ARDS) is a major cause of death among critically ill patients in intensive care settings, underscoring the need to identify biomarkers capable of predicting ARDS patient clinical status and prognosis at an early time point. This study specifically sought to explore the utility and clinical relevance of TM9SF1 as a biomarker for the early prediction of disease severity and prognostic outcomes in patients with ARDS. Methods: This study enrolled 123 patients with severe ARDS and 116 patients with non-severe ARDS for whom follow-up information was available. The mRNA levels of TM9SF1 and cytokines in peripheral blood mononuclear cells from these patients were evaluated by qPCR. The predictive performance of TM9SF1 and other clinical indicators was evaluated using received operating characteristic (ROC) curves. A predictive nomogram was developed based on TM9SF1 expression and evaluated for its ability in the early prediction of severe disease and mortality in patients with ARDS. Results: TM9SF1 mRNA expression was found to be significantly increased in patients with severe ARDS relative to those with non-severe disease or healthy controls. ARDS severity increased in correspondence with the level of TM9SF1 expression (odds ratio [OR] = 2.43, 95% confidence interval [CI] = 2.15–3.72, P = 0.005), and high TM9SF1 levels were associated with a greater risk of mortality (hazard ratio [HR] = 2.27, 95% CI = 2.20–4.39, P = 0.001). ROC curves demonstrated that relative to other clinical indicators, TM9SF1 offered superior performance in the prediction of ARDS severity and mortality. A novel nomogram incorporating TM9SF1 expression together with age, D-dimer levels, and Creactive protein (CRP) levels was developed and was used to predict ARDS severity (AUC = 0.887, 95% CI = 0.715–0.943). A separate model incorporating TM9SF1 expression, age, neutrophil-lymphocyte ratio (NLR), and D-dimer levels (C-index = 0.890, 95% CI = 0.627–0.957) was also developed for predicting mortality. Conclusion: Increases in ARDS severity and patient mortality were observed with rising levels of TM9SF1 expression. TM9SF1 may thus offer utility as a novel biomarker for the early prediction of ARDS patient disease status and clinical outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
194. A comparative analysis of sivelestat sodium hydrate and ulinastatin combination therapy in the treatment of sepsis with acute respiratory distress syndrome.
- Author
-
Xu, Jian, Zhang, Chenfei, Wu, Keren, Qian, Yanhua, and Hu, Wei
- Subjects
ADULT respiratory distress syndrome ,APACHE (Disease classification system) ,URINARY trypsin inhibitor ,SEPSIS ,DRUG side effects - Abstract
Objective: This comparative analysis aimed to investigate the efficacy of Sivelestat Sodium Hydrate (SSH) combined with Ulinastatin (UTI) in the treatment of sepsis with acute respiratory distress syndrome (ARDS). Methods: A control group and an observation group were formed with eighty-four cases of patients with sepsis with ARDS, with 42 cases in each group. The control group was intravenously injected with UTI based on conventional treatment, and the observation group was injected with SSH based on the control group. Both groups were treated continuously for 7 days, and the treatment outcomes and efficacy of both groups were observed. The Murray Lung Injury Score (MLIS), Sequential Organ Failure Assessment (SOFA), and Acute Physiology and Chronic Health Evaluation II (APACHE II) were compared. Changes in respiratory function, inflammatory factors, and oxidative stress indicators were assessed. The occurrence of adverse drug reactions was recorded. Results: The total effective rate in the observation group (95.24%) was higher than that in the control group (80.95%) (P < 0.05). The mechanical ventilation time, intensive care unit (ICU) hospitalization time, and duration of antimicrobial medication in the observation group were shorter and multiple organ dysfunction syndrome incidence was lower than those in the control group (P < 0.05). The mortality rate of patients in the observation group (35.71%) was lower than that in the control group (52.38%), but there was no statistically significant difference between the two groups (P > 0.05). MLIS, SOFA, and APACHE II scores in the observation group were lower than the control group (P < 0.05). After treatment, respiratory function, inflammation, and oxidative stress were improved in the observation group (P < 0.05). Adverse reactions were not significantly different between the two groups (P > 0.05). Conclusion: The combination of SSH plus UTI improves lung injury and pulmonary ventilation function, and reduces inflammation and oxidative stress in patients with sepsis and ARDS. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
195. Design and Implementation of an Intensive Care Unit Command Center for Medical Data Fusion.
- Author
-
Feng, Wen-Sheng, Chen, Wei-Cheng, Lin, Jiun-Yi, Tseng, How-Yang, Chen, Chieh-Lung, Chou, Ching-Yao, Cho, Der-Yang, and Lin, Yi-Bing
- Subjects
- *
MULTISENSOR data fusion , *ADULT respiratory distress syndrome , *INTENSIVE care units , *MEDICAL centers , *HEALTH facilities , *ARTIFICIAL intelligence - Abstract
The rapid advancements in Artificial Intelligence of Things (AIoT) are pivotal for the healthcare sector, especially as the world approaches an aging society which will be reached by 2050. This paper presents an innovative AIoT-enabled data fusion system implemented at the CMUH Respiratory Intensive Care Unit (RICU) to address the high incidence of medical errors in ICUs, which are among the top three causes of mortality in healthcare facilities. ICU patients are particularly vulnerable to medical errors due to the complexity of their conditions and the critical nature of their care. We introduce a four-layer AIoT architecture designed to manage and deliver both real-time and non-real-time medical data within the CMUH-RICU. Our system demonstrates the capability to handle 22 TB of medical data annually with an average delay of 1.72 ms and a bandwidth of 65.66 Mbps. Additionally, we ensure the uninterrupted operation of the CMUH-RICU with a three-node streaming cluster (called Kafka), provided a failed node is repaired within 9 h, assuming a one-year node lifespan. A case study is presented where the AI application of acute respiratory distress syndrome (ARDS), leveraging our AIoT data fusion approach, significantly improved the medical diagnosis rate from 52.2% to 93.3% and reduced mortality from 56.5% to 39.5%. The results underscore the potential of AIoT in enhancing patient outcomes and operational efficiency in the ICU setting. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
196. Outcomes and Impact of Pre-ECMO Clinical Course in Severe COVID-19-Related ARDS Treated with VV-ECMO: Data from an Italian Referral ECMO Center.
- Author
-
Sales, Gabriele, Montrucchio, Giorgia, Sanna, Valentina, Collino, Francesca, Fanelli, Vito, Filippini, Claudia, Simonetti, Umberto, Bonetto, Chiara, Morscio, Monica, Verderosa, Ivo, Urbino, Rosario, and Brazzi, Luca
- Subjects
- *
EXTRACORPOREAL membrane oxygenation , *INTENSIVE care units , *HOSPITAL mortality , *PROGNOSIS , *ADULT respiratory distress syndrome - Abstract
Background: The efficacy of veno-venous extracorporeal membrane oxygenation (VV-ECMO) as rescue therapy for refractory COVID-19-related ARDS (C-ARDS) is still debated. We describe the cohort of C-ARDS patients treated with VV-ECMO at our ECMO center, focusing on factors that may affect in-hospital mortality and describing the time course of lung mechanics to assess prognosis. Methods: We performed a prospective observational study in the intensive care unit at the "Città della Salute e della Scienza" University Hospital in Turin, Italy, between March 2020 and December 2021. Indications and management of ECMO followed the Extracorporeal Life Support Organization (ELSO) guidelines. Results: The 60-day in-hospital mortality was particularly high (85.4%). Non-survivor patients were more frequently treated with non-invasive ventilatory support and steroids before ECMO (95.1% vs. 57.1%, p = 0.018 and 73.2% vs. 28.6%, p = 0.033, respectively), while hypertension was the only pre-ECMO factor independently associated with in-hospital mortality (HR: 2.06, 95%CI: 1.06–4.00). High rates of bleeding (85.4%) and superinfections (91.7%) were recorded during ECMO, likely affecting the overall length of ECMO (18 days, IQR: 10–24) and the hospital stay (32 days, IQR: 24–47). Static lung compliance was lower in non-survivors (p = 0.031) and differed over time (p = 0.049), decreasing by 48% compared to initial values in non-survivors. Conclusions: Our data suggest the importance of considering NIS among the common ECMO eligibility criteria and changes in lung compliance during ECMO as a prognostic marker. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
197. Predictive value of invasive mechanical ventilation parameters for mortality in COVID-19 related ARDS: a retrospective cohort study.
- Author
-
Gutiérrez, Luis, Araya, Karina, Becerra, Mara, Pérez, Camilo, Valenzuela, Jorge, Lera, Lydia, Lizana, Pablo A., del Sol, Mariano, and Muñoz-Cofré, Rodrigo
- Subjects
- *
ARTIFICIAL respiration , *POSITIVE pressure ventilation , *COVID-19 , *ADULT respiratory distress syndrome , *INTENSIVE care units , *COHORT analysis , *RESPIRATORY therapists - Abstract
The 2019 coronavirus (COVID-19) can generate acute respiratory distress syndrome (ARDS), requiring advanced management within the Intensive Care Unit (ICU) using invasive mechanical ventilation (IMV However, managing this phenomenon has seen learning and improvements through direct experience. Therefore, this study aims were to describe the assessment of the different IMV variables in patients with post-COVID-19 hospitalized in the ICU and their relation with mortality. Observational and retrospective study. The sample was divided into two, the surviving group (SG) and the non-surviving group (NSG). Clinical data were extracted from the electronic clinical file and the respiratory therapist record sheet. The following information was obtained: Patient medical history: gender, age, co-morbidities, arterial gases, days on IMV, and IMV parameters. Out of a total of 101 patients, the total mortality was 32%. There was a significant decrease in respiratory rate (RR) (29.12 ± 4.24–26.78 ± 3.59, p = 0.006), Driving pressure (DP) (11.33 ± 2.39–9.67 ± 1.84, p = 0.002), Ventilatory rate (VR) (2.26 ± 0.66–1.89 ± 0.45, p = 0.001) and a significant rise in Static compliance (Cest) (35.49 ± 8.64–41.45 ± 9.62, p = 0.003) and relation between Arterial oxygen pressure/Inspirated oxygen fraction (PaO2/FiO2) (201.5 ± 53.98- 227.8 ± 52.11, p = 0.008) after 72 h of IMV, within the NSG compared to the SG. Apart from these points, multi-morbidity (HR = 3.208, p = 0.010) and DP (HR = 1.228, p = 0.030) and VR variables (HR = 2.267, p = 0.027) had more death probabilities. The results of this study indicate that there was a significant increase in RR, DP, VR, and CO2 and a significant drop in Cest and PaO2/FiO2 among the NSG compared with the SG. Apart from this, the DP and VR variables, multi-morbidity and being male. have more possibility of death. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
198. An update on the pharmacological management of acute respiratory distress syndrome.
- Author
-
Battaglini, Denise, Iavarone, Ida Giorgia, and Rocco, Patricia R. M.
- Subjects
ADULT respiratory distress syndrome ,PHARMACOLOGY ,HYPOXEMIA ,CRITICALLY ill patient care ,CLINICAL trials - Abstract
Acute respiratory distress syndrome (ARDS) is characterized by acute inflammatory injury to the lungs, alterations in vascular permeability, loss of aerated tissue, bilateral infiltrates, and refractory hypoxemia. ARDS is considered a heterogeneous syndrome, which complicates the search for effective therapies. The goal of this review is to provide an update on the pharmacological management of ARDS. The difficulties in finding effective pharmacological therapies are mainly due to the challenges in designing clinical trials for this unique, varied population of critically ill patients. Recently, some trials have been retrospectively analyzed by dividing patients into hyper-inflammatory and hypo-inflammatory sub-phenotypes. This approach has led to significant outcome improvements with some pharmacological treatments that previously failed to demonstrate efficacy, which suggests that a more precise selection of ARDS patients for clinical trials could be the key to identifying effective pharmacotherapies. This review is provided after searching the main studies on this topics on the PubMed and clinicaltrials.gov databases. The future of ARDS therapy lies in precision medicine, innovative approaches to drug delivery, immunomodulation, cell-based therapies, and robust clinical trial designs. These should lead to more effective and personalized treatments for patients with ARDS. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
199. Limiting Overdistention or Collapse When Mechanically Ventilating Injured Lungs: A Randomized Study in a Porcine Model.
- Author
-
Sousa, Mayson L. A., Katira, Bhushan H., Bouch, Sheena, Hsing, Vanessa, Engelberts, Doreen, Amato, Marcelo B. P., Post, Martin, and Brochard, Laurent J.
- Subjects
ARTIFICIAL respiration ,ELECTRICAL impedance tomography ,POSITIVE end-expiratory pressure ,ADULT respiratory distress syndrome ,LUNGS - Abstract
Rationale: It is unknown whether preventing overdistention or collapse is more important when titrating positive end-expiratory pressure (PEEP) in acute respiratory distress syndrome (ARDS). Objectives: To compare PEEP targeting minimal overdistention or minimal collapse or using a compromise between collapse and overdistention in a randomized trial and to assess the impact on respiratory mechanics, gas exchange, inflammation, and hemodynamics. Methods: In a porcine model of ARDS, lung collapse and overdistention were estimated using electrical impedance tomography during a decremental PEEP titration. Pigs were randomized to three groups and ventilated for 12 hours: PEEP set at ⩽3% of overdistention (low overdistention), ⩽3% of collapse (low collapse), and the crossing point of collapse and overdistention. Measurements and Main Results: Thirty-six pigs (12 per group) were included. Median (interquartile range) values of PEEP were 7 (6–8), 11 (10–11), and 15 (12–16) cm H
2 O in the three groups (P < 0.001). With low overdistension, 6 (50%) pigs died, whereas survival was 100% in both other groups. Cause of death was hemodynamic in nature, with high transpulmonary vascular gradient and high epinephrine requirements. Compared with the other groups, pigs surviving with low overdistension had worse respiratory mechanics and gas exchange during the entire protocol. Minimal differences existed between crossing-point and low-collapse animals in physiological parameters, but postmortem alveolar density was more homogeneous in the crossing-point group. Inflammatory markers were not significantly different. Conclusions: PEEP to minimize overdistention resulted in high mortality in an animal model of ARDS. Minimizing collapse or choosing a compromise between collapse and overdistention may result in less lung injury, with potential benefits of the compromise approach. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
200. Electrical Impedance Tomography: A Monitoring Tool for Ventilation-induced Lung Injury.
- Author
-
Fratti, Isabella, Pozzi, Tommaso, Hahn, Guenter, Fioccola, Antonio, Nicolardi, Rosmery V., Busana, Mattia, Collino, Francesca, Moerer, Onnen, Camporota, Luigi, and Gattinoni, Luciano
- Subjects
ELECTRICAL impedance tomography ,RESPIRATORY mechanics ,ELECTRICAL injuries ,LUNG injuries ,ADULT respiratory distress syndrome - Abstract
The article focuses on investigating whether electrical impedance tomography (EIT) can detect the onset and progression of ventilator-induced lung injury (VILI) in an animal model of VILI. It is reported that the study involved a retrospective analysis of healthy female domestic pigs ventilated for 48 hours, aiming to assess changes in lung electrical impedance compared to other parameters such as oxygenation, respiratory mechanics, and lung pathology.
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.